Global Burn and Scald Medicine Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Description

According to our (Global Info Research) latest study, the global Burn and Scald Medicine market size was valued at US$ 4649 million in 2024 and is forecast to a readjusted size of USD 6498 million by 2031 with a CAGR of 4.9% during review period.

Burn and scald medicine refers to a kind of medicine used to treat skin and tissue damage caused by heat, chemical substances, electric shock or radiation. These drugs are designed to reduce pain, prevent infection, promote wound healing, and minimize scar formation, focusing on the most commonly used burn wound dressings and topical drugs in adults and children.

This report is a detailed and comprehensive analysis for global Burn and Scald Medicine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:
Global Burn and Scald Medicine market size and forecasts, in consumption value ($ Million), 2020-2031
Global Burn and Scald Medicine market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Burn and Scald Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Burn and Scald Medicine market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Burn and Scald Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Burn and Scald Medicine market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nipro, MediWound, STADA Arzneimittel, Elastoplast, Pfizer, Bharat Biotech, Paul Hartmann, Ono Pharmaceutical, Centaur Pharmaceuticals, Kedrion Biopharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Burn and Scald Medicine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Dressing
    Ointment
    Spray

Market segment by Application
    Hospital
    Clinic
    Pharmacy
    Online

Market segment by players, this report covers
    Nipro
    MediWound
    STADA Arzneimittel
    Elastoplast
    Pfizer
    Bharat Biotech
    Paul Hartmann
    Ono Pharmaceutical
    Centaur Pharmaceuticals
    Kedrion Biopharma
    Smith & Nephew
    ConvaTec
    B. Braun Melsungen
    Coloplast
    Mölnlycke Health Care
    Medline Industries
    Hartmann
    Ferndale Pharmaceuticals
    Guizhou Jingcheng Medicine
    Mebo Pharmaceutical Technology
    Shanghai Tenry Pharm
    Guilin Huanuo Gene Pharmaceutical
    Shanghai Haohai Biotechnology
    Beijing SL Pharmaceutical
    Hubei Mayinglong Pharmaceutical
    Jianmin Group
    Tianjin Pharm Group
    Cardinal Health
    Integra LifeSciences
    Deroyal
    DermaRite Industries

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Burn and Scald Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Burn and Scald Medicine, with revenue, gross margin, and global market share of Burn and Scald Medicine from 2020 to 2025.
Chapter 3, the Burn and Scald Medicine competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Burn and Scald Medicine market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Burn and Scald Medicine.
Chapter 13, to describe Burn and Scald Medicine research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Burn and Scald Medicine by Type
        1.3.1 Overview: Global Burn and Scald Medicine Market Size by Type: 2020 Versus 2024 Versus 2031
        1.3.2 Global Burn and Scald Medicine Consumption Value Market Share by Type in 2024
        1.3.3 Dressing
        1.3.4 Ointment
        1.3.5 Spray
    1.4 Global Burn and Scald Medicine Market by Application
        1.4.1 Overview: Global Burn and Scald Medicine Market Size by Application: 2020 Versus 2024 Versus 2031
        1.4.2 Hospital
        1.4.3 Clinic
        1.4.4 Pharmacy
        1.4.5 Online
    1.5 Global Burn and Scald Medicine Market Size & Forecast
    1.6 Global Burn and Scald Medicine Market Size and Forecast by Region
        1.6.1 Global Burn and Scald Medicine Market Size by Region: 2020 VS 2024 VS 2031
        1.6.2 Global Burn and Scald Medicine Market Size by Region, (2020-2031)
        1.6.3 North America Burn and Scald Medicine Market Size and Prospect (2020-2031)
        1.6.4 Europe Burn and Scald Medicine Market Size and Prospect (2020-2031)
        1.6.5 Asia-Pacific Burn and Scald Medicine Market Size and Prospect (2020-2031)
        1.6.6 South America Burn and Scald Medicine Market Size and Prospect (2020-2031)
        1.6.7 Middle East & Africa Burn and Scald Medicine Market Size and Prospect (2020-2031)

2 Company Profiles
    2.1 Nipro
        2.1.1 Nipro Details
        2.1.2 Nipro Major Business
        2.1.3 Nipro Burn and Scald Medicine Product and Solutions
        2.1.4 Nipro Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.1.5 Nipro Recent Developments and Future Plans
    2.2 MediWound
        2.2.1 MediWound Details
        2.2.2 MediWound Major Business
        2.2.3 MediWound Burn and Scald Medicine Product and Solutions
        2.2.4 MediWound Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.2.5 MediWound Recent Developments and Future Plans
    2.3 STADA Arzneimittel
        2.3.1 STADA Arzneimittel Details
        2.3.2 STADA Arzneimittel Major Business
        2.3.3 STADA Arzneimittel Burn and Scald Medicine Product and Solutions
        2.3.4 STADA Arzneimittel Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.3.5 STADA Arzneimittel Recent Developments and Future Plans
    2.4 Elastoplast
        2.4.1 Elastoplast Details
        2.4.2 Elastoplast Major Business
        2.4.3 Elastoplast Burn and Scald Medicine Product and Solutions
        2.4.4 Elastoplast Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.4.5 Elastoplast Recent Developments and Future Plans
    2.5 Pfizer
        2.5.1 Pfizer Details
        2.5.2 Pfizer Major Business
        2.5.3 Pfizer Burn and Scald Medicine Product and Solutions
        2.5.4 Pfizer Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.5.5 Pfizer Recent Developments and Future Plans
    2.6 Bharat Biotech
        2.6.1 Bharat Biotech Details
        2.6.2 Bharat Biotech Major Business
        2.6.3 Bharat Biotech Burn and Scald Medicine Product and Solutions
        2.6.4 Bharat Biotech Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.6.5 Bharat Biotech Recent Developments and Future Plans
    2.7 Paul Hartmann
        2.7.1 Paul Hartmann Details
        2.7.2 Paul Hartmann Major Business
        2.7.3 Paul Hartmann Burn and Scald Medicine Product and Solutions
        2.7.4 Paul Hartmann Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.7.5 Paul Hartmann Recent Developments and Future Plans
    2.8 Ono Pharmaceutical
        2.8.1 Ono Pharmaceutical Details
        2.8.2 Ono Pharmaceutical Major Business
        2.8.3 Ono Pharmaceutical Burn and Scald Medicine Product and Solutions
        2.8.4 Ono Pharmaceutical Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.8.5 Ono Pharmaceutical Recent Developments and Future Plans
    2.9 Centaur Pharmaceuticals
        2.9.1 Centaur Pharmaceuticals Details
        2.9.2 Centaur Pharmaceuticals Major Business
        2.9.3 Centaur Pharmaceuticals Burn and Scald Medicine Product and Solutions
        2.9.4 Centaur Pharmaceuticals Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.9.5 Centaur Pharmaceuticals Recent Developments and Future Plans
    2.10 Kedrion Biopharma
        2.10.1 Kedrion Biopharma Details
        2.10.2 Kedrion Biopharma Major Business
        2.10.3 Kedrion Biopharma Burn and Scald Medicine Product and Solutions
        2.10.4 Kedrion Biopharma Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.10.5 Kedrion Biopharma Recent Developments and Future Plans
    2.11 Smith & Nephew
        2.11.1 Smith & Nephew Details
        2.11.2 Smith & Nephew Major Business
        2.11.3 Smith & Nephew Burn and Scald Medicine Product and Solutions
        2.11.4 Smith & Nephew Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.11.5 Smith & Nephew Recent Developments and Future Plans
    2.12 ConvaTec
        2.12.1 ConvaTec Details
        2.12.2 ConvaTec Major Business
        2.12.3 ConvaTec Burn and Scald Medicine Product and Solutions
        2.12.4 ConvaTec Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.12.5 ConvaTec Recent Developments and Future Plans
    2.13 B. Braun Melsungen
        2.13.1 B. Braun Melsungen Details
        2.13.2 B. Braun Melsungen Major Business
        2.13.3 B. Braun Melsungen Burn and Scald Medicine Product and Solutions
        2.13.4 B. Braun Melsungen Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.13.5 B. Braun Melsungen Recent Developments and Future Plans
    2.14 Coloplast
        2.14.1 Coloplast Details
        2.14.2 Coloplast Major Business
        2.14.3 Coloplast Burn and Scald Medicine Product and Solutions
        2.14.4 Coloplast Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.14.5 Coloplast Recent Developments and Future Plans
    2.15 Mölnlycke Health Care
        2.15.1 Mölnlycke Health Care Details
        2.15.2 Mölnlycke Health Care Major Business
        2.15.3 Mölnlycke Health Care Burn and Scald Medicine Product and Solutions
        2.15.4 Mölnlycke Health Care Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.15.5 Mölnlycke Health Care Recent Developments and Future Plans
    2.16 Medline Industries
        2.16.1 Medline Industries Details
        2.16.2 Medline Industries Major Business
        2.16.3 Medline Industries Burn and Scald Medicine Product and Solutions
        2.16.4 Medline Industries Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.16.5 Medline Industries Recent Developments and Future Plans
    2.17 Hartmann
        2.17.1 Hartmann Details
        2.17.2 Hartmann Major Business
        2.17.3 Hartmann Burn and Scald Medicine Product and Solutions
        2.17.4 Hartmann Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.17.5 Hartmann Recent Developments and Future Plans
    2.18 Ferndale Pharmaceuticals
        2.18.1 Ferndale Pharmaceuticals Details
        2.18.2 Ferndale Pharmaceuticals Major Business
        2.18.3 Ferndale Pharmaceuticals Burn and Scald Medicine Product and Solutions
        2.18.4 Ferndale Pharmaceuticals Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.18.5 Ferndale Pharmaceuticals Recent Developments and Future Plans
    2.19 Guizhou Jingcheng Medicine
        2.19.1 Guizhou Jingcheng Medicine Details
        2.19.2 Guizhou Jingcheng Medicine Major Business
        2.19.3 Guizhou Jingcheng Medicine Burn and Scald Medicine Product and Solutions
        2.19.4 Guizhou Jingcheng Medicine Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.19.5 Guizhou Jingcheng Medicine Recent Developments and Future Plans
    2.20 Mebo Pharmaceutical Technology
        2.20.1 Mebo Pharmaceutical Technology Details
        2.20.2 Mebo Pharmaceutical Technology Major Business
        2.20.3 Mebo Pharmaceutical Technology Burn and Scald Medicine Product and Solutions
        2.20.4 Mebo Pharmaceutical Technology Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.20.5 Mebo Pharmaceutical Technology Recent Developments and Future Plans
    2.21 Shanghai Tenry Pharm
        2.21.1 Shanghai Tenry Pharm Details
        2.21.2 Shanghai Tenry Pharm Major Business
        2.21.3 Shanghai Tenry Pharm Burn and Scald Medicine Product and Solutions
        2.21.4 Shanghai Tenry Pharm Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.21.5 Shanghai Tenry Pharm Recent Developments and Future Plans
    2.22 Guilin Huanuo Gene Pharmaceutical
        2.22.1 Guilin Huanuo Gene Pharmaceutical Details
        2.22.2 Guilin Huanuo Gene Pharmaceutical Major Business
        2.22.3 Guilin Huanuo Gene Pharmaceutical Burn and Scald Medicine Product and Solutions
        2.22.4 Guilin Huanuo Gene Pharmaceutical Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.22.5 Guilin Huanuo Gene Pharmaceutical Recent Developments and Future Plans
    2.23 Shanghai Haohai Biotechnology
        2.23.1 Shanghai Haohai Biotechnology Details
        2.23.2 Shanghai Haohai Biotechnology Major Business
        2.23.3 Shanghai Haohai Biotechnology Burn and Scald Medicine Product and Solutions
        2.23.4 Shanghai Haohai Biotechnology Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.23.5 Shanghai Haohai Biotechnology Recent Developments and Future Plans
    2.24 Beijing SL Pharmaceutical
        2.24.1 Beijing SL Pharmaceutical Details
        2.24.2 Beijing SL Pharmaceutical Major Business
        2.24.3 Beijing SL Pharmaceutical Burn and Scald Medicine Product and Solutions
        2.24.4 Beijing SL Pharmaceutical Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.24.5 Beijing SL Pharmaceutical Recent Developments and Future Plans
    2.25 Hubei Mayinglong Pharmaceutical
        2.25.1 Hubei Mayinglong Pharmaceutical Details
        2.25.2 Hubei Mayinglong Pharmaceutical Major Business
        2.25.3 Hubei Mayinglong Pharmaceutical Burn and Scald Medicine Product and Solutions
        2.25.4 Hubei Mayinglong Pharmaceutical Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.25.5 Hubei Mayinglong Pharmaceutical Recent Developments and Future Plans
    2.26 Jianmin Group
        2.26.1 Jianmin Group Details
        2.26.2 Jianmin Group Major Business
        2.26.3 Jianmin Group Burn and Scald Medicine Product and Solutions
        2.26.4 Jianmin Group Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.26.5 Jianmin Group Recent Developments and Future Plans
    2.27 Tianjin Pharm Group
        2.27.1 Tianjin Pharm Group Details
        2.27.2 Tianjin Pharm Group Major Business
        2.27.3 Tianjin Pharm Group Burn and Scald Medicine Product and Solutions
        2.27.4 Tianjin Pharm Group Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.27.5 Tianjin Pharm Group Recent Developments and Future Plans
    2.28 Cardinal Health
        2.28.1 Cardinal Health Details
        2.28.2 Cardinal Health Major Business
        2.28.3 Cardinal Health Burn and Scald Medicine Product and Solutions
        2.28.4 Cardinal Health Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.28.5 Cardinal Health Recent Developments and Future Plans
    2.29 Integra LifeSciences
        2.29.1 Integra LifeSciences Details
        2.29.2 Integra LifeSciences Major Business
        2.29.3 Integra LifeSciences Burn and Scald Medicine Product and Solutions
        2.29.4 Integra LifeSciences Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.29.5 Integra LifeSciences Recent Developments and Future Plans
    2.30 Deroyal
        2.30.1 Deroyal Details
        2.30.2 Deroyal Major Business
        2.30.3 Deroyal Burn and Scald Medicine Product and Solutions
        2.30.4 Deroyal Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.30.5 Deroyal Recent Developments and Future Plans
    2.31 DermaRite Industries
        2.31.1 DermaRite Industries Details
        2.31.2 DermaRite Industries Major Business
        2.31.3 DermaRite Industries Burn and Scald Medicine Product and Solutions
        2.31.4 DermaRite Industries Burn and Scald Medicine Revenue, Gross Margin and Market Share (2020-2025)
        2.31.5 DermaRite Industries Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Burn and Scald Medicine Revenue and Share by Players (2020-2025)
    3.2 Market Share Analysis (2024)
        3.2.1 Market Share of Burn and Scald Medicine by Company Revenue
        3.2.2 Top 3 Burn and Scald Medicine Players Market Share in 2024
        3.2.3 Top 6 Burn and Scald Medicine Players Market Share in 2024
    3.3 Burn and Scald Medicine Market: Overall Company Footprint Analysis
        3.3.1 Burn and Scald Medicine Market: Region Footprint
        3.3.2 Burn and Scald Medicine Market: Company Product Type Footprint
        3.3.3 Burn and Scald Medicine Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Burn and Scald Medicine Consumption Value and Market Share by Type (2020-2025)
    4.2 Global Burn and Scald Medicine Market Forecast by Type (2026-2031)

5 Market Size Segment by Application
    5.1 Global Burn and Scald Medicine Consumption Value Market Share by Application (2020-2025)
    5.2 Global Burn and Scald Medicine Market Forecast by Application (2026-2031)

6 North America
    6.1 North America Burn and Scald Medicine Consumption Value by Type (2020-2031)
    6.2 North America Burn and Scald Medicine Market Size by Application (2020-2031)
    6.3 North America Burn and Scald Medicine Market Size by Country
        6.3.1 North America Burn and Scald Medicine Consumption Value by Country (2020-2031)
        6.3.2 United States Burn and Scald Medicine Market Size and Forecast (2020-2031)
        6.3.3 Canada Burn and Scald Medicine Market Size and Forecast (2020-2031)
        6.3.4 Mexico Burn and Scald Medicine Market Size and Forecast (2020-2031)

7 Europe
    7.1 Europe Burn and Scald Medicine Consumption Value by Type (2020-2031)
    7.2 Europe Burn and Scald Medicine Consumption Value by Application (2020-2031)
    7.3 Europe Burn and Scald Medicine Market Size by Country
        7.3.1 Europe Burn and Scald Medicine Consumption Value by Country (2020-2031)
        7.3.2 Germany Burn and Scald Medicine Market Size and Forecast (2020-2031)
        7.3.3 France Burn and Scald Medicine Market Size and Forecast (2020-2031)
        7.3.4 United Kingdom Burn and Scald Medicine Market Size and Forecast (2020-2031)
        7.3.5 Russia Burn and Scald Medicine Market Size and Forecast (2020-2031)
        7.3.6 Italy Burn and Scald Medicine Market Size and Forecast (2020-2031)

8 Asia-Pacific
    8.1 Asia-Pacific Burn and Scald Medicine Consumption Value by Type (2020-2031)
    8.2 Asia-Pacific Burn and Scald Medicine Consumption Value by Application (2020-2031)
    8.3 Asia-Pacific Burn and Scald Medicine Market Size by Region
        8.3.1 Asia-Pacific Burn and Scald Medicine Consumption Value by Region (2020-2031)
        8.3.2 China Burn and Scald Medicine Market Size and Forecast (2020-2031)
        8.3.3 Japan Burn and Scald Medicine Market Size and Forecast (2020-2031)
        8.3.4 South Korea Burn and Scald Medicine Market Size and Forecast (2020-2031)
        8.3.5 India Burn and Scald Medicine Market Size and Forecast (2020-2031)
        8.3.6 Southeast Asia Burn and Scald Medicine Market Size and Forecast (2020-2031)
        8.3.7 Australia Burn and Scald Medicine Market Size and Forecast (2020-2031)

9 South America
    9.1 South America Burn and Scald Medicine Consumption Value by Type (2020-2031)
    9.2 South America Burn and Scald Medicine Consumption Value by Application (2020-2031)
    9.3 South America Burn and Scald Medicine Market Size by Country
        9.3.1 South America Burn and Scald Medicine Consumption Value by Country (2020-2031)
        9.3.2 Brazil Burn and Scald Medicine Market Size and Forecast (2020-2031)
        9.3.3 Argentina Burn and Scald Medicine Market Size and Forecast (2020-2031)

10 Middle East & Africa
    10.1 Middle East & Africa Burn and Scald Medicine Consumption Value by Type (2020-2031)
    10.2 Middle East & Africa Burn and Scald Medicine Consumption Value by Application (2020-2031)
    10.3 Middle East & Africa Burn and Scald Medicine Market Size by Country
        10.3.1 Middle East & Africa Burn and Scald Medicine Consumption Value by Country (2020-2031)
        10.3.2 Turkey Burn and Scald Medicine Market Size and Forecast (2020-2031)
        10.3.3 Saudi Arabia Burn and Scald Medicine Market Size and Forecast (2020-2031)
        10.3.4 UAE Burn and Scald Medicine Market Size and Forecast (2020-2031)

11 Market Dynamics
    11.1 Burn and Scald Medicine Market Drivers
    11.2 Burn and Scald Medicine Market Restraints
    11.3 Burn and Scald Medicine Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Burn and Scald Medicine Industry Chain
    12.2 Burn and Scald Medicine Upstream Analysis
    12.3 Burn and Scald Medicine Midstream Analysis
    12.4 Burn and Scald Medicine Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Burn and Scald Medicine Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Table 2. Global Burn and Scald Medicine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Table 3. Global Burn and Scald Medicine Consumption Value by Region (2020-2025) & (USD Million)
 Table 4. Global Burn and Scald Medicine Consumption Value by Region (2026-2031) & (USD Million)
 Table 5. Nipro Company Information, Head Office, and Major Competitors
 Table 6. Nipro Major Business
 Table 7. Nipro Burn and Scald Medicine Product and Solutions
 Table 8. Nipro Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 9. Nipro Recent Developments and Future Plans
 Table 10. MediWound Company Information, Head Office, and Major Competitors
 Table 11. MediWound Major Business
 Table 12. MediWound Burn and Scald Medicine Product and Solutions
 Table 13. MediWound Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 14. MediWound Recent Developments and Future Plans
 Table 15. STADA Arzneimittel Company Information, Head Office, and Major Competitors
 Table 16. STADA Arzneimittel Major Business
 Table 17. STADA Arzneimittel Burn and Scald Medicine Product and Solutions
 Table 18. STADA Arzneimittel Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 19. Elastoplast Company Information, Head Office, and Major Competitors
 Table 20. Elastoplast Major Business
 Table 21. Elastoplast Burn and Scald Medicine Product and Solutions
 Table 22. Elastoplast Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 23. Elastoplast Recent Developments and Future Plans
 Table 24. Pfizer Company Information, Head Office, and Major Competitors
 Table 25. Pfizer Major Business
 Table 26. Pfizer Burn and Scald Medicine Product and Solutions
 Table 27. Pfizer Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 28. Pfizer Recent Developments and Future Plans
 Table 29. Bharat Biotech Company Information, Head Office, and Major Competitors
 Table 30. Bharat Biotech Major Business
 Table 31. Bharat Biotech Burn and Scald Medicine Product and Solutions
 Table 32. Bharat Biotech Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 33. Bharat Biotech Recent Developments and Future Plans
 Table 34. Paul Hartmann Company Information, Head Office, and Major Competitors
 Table 35. Paul Hartmann Major Business
 Table 36. Paul Hartmann Burn and Scald Medicine Product and Solutions
 Table 37. Paul Hartmann Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 38. Paul Hartmann Recent Developments and Future Plans
 Table 39. Ono Pharmaceutical Company Information, Head Office, and Major Competitors
 Table 40. Ono Pharmaceutical Major Business
 Table 41. Ono Pharmaceutical Burn and Scald Medicine Product and Solutions
 Table 42. Ono Pharmaceutical Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 43. Ono Pharmaceutical Recent Developments and Future Plans
 Table 44. Centaur Pharmaceuticals Company Information, Head Office, and Major Competitors
 Table 45. Centaur Pharmaceuticals Major Business
 Table 46. Centaur Pharmaceuticals Burn and Scald Medicine Product and Solutions
 Table 47. Centaur Pharmaceuticals Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 48. Centaur Pharmaceuticals Recent Developments and Future Plans
 Table 49. Kedrion Biopharma Company Information, Head Office, and Major Competitors
 Table 50. Kedrion Biopharma Major Business
 Table 51. Kedrion Biopharma Burn and Scald Medicine Product and Solutions
 Table 52. Kedrion Biopharma Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 53. Kedrion Biopharma Recent Developments and Future Plans
 Table 54. Smith & Nephew Company Information, Head Office, and Major Competitors
 Table 55. Smith & Nephew Major Business
 Table 56. Smith & Nephew Burn and Scald Medicine Product and Solutions
 Table 57. Smith & Nephew Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 58. Smith & Nephew Recent Developments and Future Plans
 Table 59. ConvaTec Company Information, Head Office, and Major Competitors
 Table 60. ConvaTec Major Business
 Table 61. ConvaTec Burn and Scald Medicine Product and Solutions
 Table 62. ConvaTec Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 63. ConvaTec Recent Developments and Future Plans
 Table 64. B. Braun Melsungen Company Information, Head Office, and Major Competitors
 Table 65. B. Braun Melsungen Major Business
 Table 66. B. Braun Melsungen Burn and Scald Medicine Product and Solutions
 Table 67. B. Braun Melsungen Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 68. B. Braun Melsungen Recent Developments and Future Plans
 Table 69. Coloplast Company Information, Head Office, and Major Competitors
 Table 70. Coloplast Major Business
 Table 71. Coloplast Burn and Scald Medicine Product and Solutions
 Table 72. Coloplast Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 73. Coloplast Recent Developments and Future Plans
 Table 74. Mölnlycke Health Care Company Information, Head Office, and Major Competitors
 Table 75. Mölnlycke Health Care Major Business
 Table 76. Mölnlycke Health Care Burn and Scald Medicine Product and Solutions
 Table 77. Mölnlycke Health Care Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 78. Mölnlycke Health Care Recent Developments and Future Plans
 Table 79. Medline Industries Company Information, Head Office, and Major Competitors
 Table 80. Medline Industries Major Business
 Table 81. Medline Industries Burn and Scald Medicine Product and Solutions
 Table 82. Medline Industries Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 83. Medline Industries Recent Developments and Future Plans
 Table 84. Hartmann Company Information, Head Office, and Major Competitors
 Table 85. Hartmann Major Business
 Table 86. Hartmann Burn and Scald Medicine Product and Solutions
 Table 87. Hartmann Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 88. Hartmann Recent Developments and Future Plans
 Table 89. Ferndale Pharmaceuticals Company Information, Head Office, and Major Competitors
 Table 90. Ferndale Pharmaceuticals Major Business
 Table 91. Ferndale Pharmaceuticals Burn and Scald Medicine Product and Solutions
 Table 92. Ferndale Pharmaceuticals Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 93. Ferndale Pharmaceuticals Recent Developments and Future Plans
 Table 94. Guizhou Jingcheng Medicine Company Information, Head Office, and Major Competitors
 Table 95. Guizhou Jingcheng Medicine Major Business
 Table 96. Guizhou Jingcheng Medicine Burn and Scald Medicine Product and Solutions
 Table 97. Guizhou Jingcheng Medicine Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 98. Guizhou Jingcheng Medicine Recent Developments and Future Plans
 Table 99. Mebo Pharmaceutical Technology Company Information, Head Office, and Major Competitors
 Table 100. Mebo Pharmaceutical Technology Major Business
 Table 101. Mebo Pharmaceutical Technology Burn and Scald Medicine Product and Solutions
 Table 102. Mebo Pharmaceutical Technology Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 103. Mebo Pharmaceutical Technology Recent Developments and Future Plans
 Table 104. Shanghai Tenry Pharm Company Information, Head Office, and Major Competitors
 Table 105. Shanghai Tenry Pharm Major Business
 Table 106. Shanghai Tenry Pharm Burn and Scald Medicine Product and Solutions
 Table 107. Shanghai Tenry Pharm Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 108. Shanghai Tenry Pharm Recent Developments and Future Plans
 Table 109. Guilin Huanuo Gene Pharmaceutical Company Information, Head Office, and Major Competitors
 Table 110. Guilin Huanuo Gene Pharmaceutical Major Business
 Table 111. Guilin Huanuo Gene Pharmaceutical Burn and Scald Medicine Product and Solutions
 Table 112. Guilin Huanuo Gene Pharmaceutical Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 113. Guilin Huanuo Gene Pharmaceutical Recent Developments and Future Plans
 Table 114. Shanghai Haohai Biotechnology Company Information, Head Office, and Major Competitors
 Table 115. Shanghai Haohai Biotechnology Major Business
 Table 116. Shanghai Haohai Biotechnology Burn and Scald Medicine Product and Solutions
 Table 117. Shanghai Haohai Biotechnology Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 118. Shanghai Haohai Biotechnology Recent Developments and Future Plans
 Table 119. Beijing SL Pharmaceutical Company Information, Head Office, and Major Competitors
 Table 120. Beijing SL Pharmaceutical Major Business
 Table 121. Beijing SL Pharmaceutical Burn and Scald Medicine Product and Solutions
 Table 122. Beijing SL Pharmaceutical Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 123. Beijing SL Pharmaceutical Recent Developments and Future Plans
 Table 124. Hubei Mayinglong Pharmaceutical Company Information, Head Office, and Major Competitors
 Table 125. Hubei Mayinglong Pharmaceutical Major Business
 Table 126. Hubei Mayinglong Pharmaceutical Burn and Scald Medicine Product and Solutions
 Table 127. Hubei Mayinglong Pharmaceutical Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 128. Hubei Mayinglong Pharmaceutical Recent Developments and Future Plans
 Table 129. Jianmin Group Company Information, Head Office, and Major Competitors
 Table 130. Jianmin Group Major Business
 Table 131. Jianmin Group Burn and Scald Medicine Product and Solutions
 Table 132. Jianmin Group Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 133. Jianmin Group Recent Developments and Future Plans
 Table 134. Tianjin Pharm Group Company Information, Head Office, and Major Competitors
 Table 135. Tianjin Pharm Group Major Business
 Table 136. Tianjin Pharm Group Burn and Scald Medicine Product and Solutions
 Table 137. Tianjin Pharm Group Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 138. Tianjin Pharm Group Recent Developments and Future Plans
 Table 139. Cardinal Health Company Information, Head Office, and Major Competitors
 Table 140. Cardinal Health Major Business
 Table 141. Cardinal Health Burn and Scald Medicine Product and Solutions
 Table 142. Cardinal Health Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 143. Cardinal Health Recent Developments and Future Plans
 Table 144. Integra LifeSciences Company Information, Head Office, and Major Competitors
 Table 145. Integra LifeSciences Major Business
 Table 146. Integra LifeSciences Burn and Scald Medicine Product and Solutions
 Table 147. Integra LifeSciences Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 148. Integra LifeSciences Recent Developments and Future Plans
 Table 149. Deroyal Company Information, Head Office, and Major Competitors
 Table 150. Deroyal Major Business
 Table 151. Deroyal Burn and Scald Medicine Product and Solutions
 Table 152. Deroyal Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 153. Deroyal Recent Developments and Future Plans
 Table 154. DermaRite Industries Company Information, Head Office, and Major Competitors
 Table 155. DermaRite Industries Major Business
 Table 156. DermaRite Industries Burn and Scald Medicine Product and Solutions
 Table 157. DermaRite Industries Burn and Scald Medicine Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 158. DermaRite Industries Recent Developments and Future Plans
 Table 159. Global Burn and Scald Medicine Revenue (USD Million) by Players (2020-2025)
 Table 160. Global Burn and Scald Medicine Revenue Share by Players (2020-2025)
 Table 161. Breakdown of Burn and Scald Medicine by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 162. Market Position of Players in Burn and Scald Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
 Table 163. Head Office of Key Burn and Scald Medicine Players
 Table 164. Burn and Scald Medicine Market: Company Product Type Footprint
 Table 165. Burn and Scald Medicine Market: Company Product Application Footprint
 Table 166. Burn and Scald Medicine New Market Entrants and Barriers to Market Entry
 Table 167. Burn and Scald Medicine Mergers, Acquisition, Agreements, and Collaborations
 Table 168. Global Burn and Scald Medicine Consumption Value (USD Million) by Type (2020-2025)
 Table 169. Global Burn and Scald Medicine Consumption Value Share by Type (2020-2025)
 Table 170. Global Burn and Scald Medicine Consumption Value Forecast by Type (2026-2031)
 Table 171. Global Burn and Scald Medicine Consumption Value by Application (2020-2025)
 Table 172. Global Burn and Scald Medicine Consumption Value Forecast by Application (2026-2031)
 Table 173. North America Burn and Scald Medicine Consumption Value by Type (2020-2025) & (USD Million)
 Table 174. North America Burn and Scald Medicine Consumption Value by Type (2026-2031) & (USD Million)
 Table 175. North America Burn and Scald Medicine Consumption Value by Application (2020-2025) & (USD Million)
 Table 176. North America Burn and Scald Medicine Consumption Value by Application (2026-2031) & (USD Million)
 Table 177. North America Burn and Scald Medicine Consumption Value by Country (2020-2025) & (USD Million)
 Table 178. North America Burn and Scald Medicine Consumption Value by Country (2026-2031) & (USD Million)
 Table 179. Europe Burn and Scald Medicine Consumption Value by Type (2020-2025) & (USD Million)
 Table 180. Europe Burn and Scald Medicine Consumption Value by Type (2026-2031) & (USD Million)
 Table 181. Europe Burn and Scald Medicine Consumption Value by Application (2020-2025) & (USD Million)
 Table 182. Europe Burn and Scald Medicine Consumption Value by Application (2026-2031) & (USD Million)
 Table 183. Europe Burn and Scald Medicine Consumption Value by Country (2020-2025) & (USD Million)
 Table 184. Europe Burn and Scald Medicine Consumption Value by Country (2026-2031) & (USD Million)
 Table 185. Asia-Pacific Burn and Scald Medicine Consumption Value by Type (2020-2025) & (USD Million)
 Table 186. Asia-Pacific Burn and Scald Medicine Consumption Value by Type (2026-2031) & (USD Million)
 Table 187. Asia-Pacific Burn and Scald Medicine Consumption Value by Application (2020-2025) & (USD Million)
 Table 188. Asia-Pacific Burn and Scald Medicine Consumption Value by Application (2026-2031) & (USD Million)
 Table 189. Asia-Pacific Burn and Scald Medicine Consumption Value by Region (2020-2025) & (USD Million)
 Table 190. Asia-Pacific Burn and Scald Medicine Consumption Value by Region (2026-2031) & (USD Million)
 Table 191. South America Burn and Scald Medicine Consumption Value by Type (2020-2025) & (USD Million)
 Table 192. South America Burn and Scald Medicine Consumption Value by Type (2026-2031) & (USD Million)
 Table 193. South America Burn and Scald Medicine Consumption Value by Application (2020-2025) & (USD Million)
 Table 194. South America Burn and Scald Medicine Consumption Value by Application (2026-2031) & (USD Million)
 Table 195. South America Burn and Scald Medicine Consumption Value by Country (2020-2025) & (USD Million)
 Table 196. South America Burn and Scald Medicine Consumption Value by Country (2026-2031) & (USD Million)
 Table 197. Middle East & Africa Burn and Scald Medicine Consumption Value by Type (2020-2025) & (USD Million)
 Table 198. Middle East & Africa Burn and Scald Medicine Consumption Value by Type (2026-2031) & (USD Million)
 Table 199. Middle East & Africa Burn and Scald Medicine Consumption Value by Application (2020-2025) & (USD Million)
 Table 200. Middle East & Africa Burn and Scald Medicine Consumption Value by Application (2026-2031) & (USD Million)
 Table 201. Middle East & Africa Burn and Scald Medicine Consumption Value by Country (2020-2025) & (USD Million)
 Table 202. Middle East & Africa Burn and Scald Medicine Consumption Value by Country (2026-2031) & (USD Million)
 Table 203. Global Key Players of Burn and Scald Medicine Upstream (Raw Materials)
 Table 204. Global Burn and Scald Medicine Typical Customers


List of Figures
 Figure 1. Burn and Scald Medicine Picture
 Figure 2. Global Burn and Scald Medicine Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Figure 3. Global Burn and Scald Medicine Consumption Value Market Share by Type in 2024
 Figure 4. Dressing
 Figure 5. Ointment
 Figure 6. Spray
 Figure 7. Global Burn and Scald Medicine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Figure 8. Burn and Scald Medicine Consumption Value Market Share by Application in 2024
 Figure 9. Hospital Picture
 Figure 10. Clinic Picture
 Figure 11. Pharmacy Picture
 Figure 12. Online Picture
 Figure 13. Global Burn and Scald Medicine Consumption Value, (USD Million): 2020 & 2024 & 2031
 Figure 14. Global Burn and Scald Medicine Consumption Value and Forecast (2020-2031) & (USD Million)
 Figure 15. Global Market Burn and Scald Medicine Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
 Figure 16. Global Burn and Scald Medicine Consumption Value Market Share by Region (2020-2031)
 Figure 17. Global Burn and Scald Medicine Consumption Value Market Share by Region in 2024
 Figure 18. North America Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 19. Europe Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 20. Asia-Pacific Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 21. South America Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 22. Middle East & Africa Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 23. Company Three Recent Developments and Future Plans
 Figure 24. Global Burn and Scald Medicine Revenue Share by Players in 2024
 Figure 25. Burn and Scald Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
 Figure 26. Market Share of Burn and Scald Medicine by Player Revenue in 2024
 Figure 27. Top 3 Burn and Scald Medicine Players Market Share in 2024
 Figure 28. Top 6 Burn and Scald Medicine Players Market Share in 2024
 Figure 29. Global Burn and Scald Medicine Consumption Value Share by Type (2020-2025)
 Figure 30. Global Burn and Scald Medicine Market Share Forecast by Type (2026-2031)
 Figure 31. Global Burn and Scald Medicine Consumption Value Share by Application (2020-2025)
 Figure 32. Global Burn and Scald Medicine Market Share Forecast by Application (2026-2031)
 Figure 33. North America Burn and Scald Medicine Consumption Value Market Share by Type (2020-2031)
 Figure 34. North America Burn and Scald Medicine Consumption Value Market Share by Application (2020-2031)
 Figure 35. North America Burn and Scald Medicine Consumption Value Market Share by Country (2020-2031)
 Figure 36. United States Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 37. Canada Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 38. Mexico Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 39. Europe Burn and Scald Medicine Consumption Value Market Share by Type (2020-2031)
 Figure 40. Europe Burn and Scald Medicine Consumption Value Market Share by Application (2020-2031)
 Figure 41. Europe Burn and Scald Medicine Consumption Value Market Share by Country (2020-2031)
 Figure 42. Germany Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 43. France Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 44. United Kingdom Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 45. Russia Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 46. Italy Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 47. Asia-Pacific Burn and Scald Medicine Consumption Value Market Share by Type (2020-2031)
 Figure 48. Asia-Pacific Burn and Scald Medicine Consumption Value Market Share by Application (2020-2031)
 Figure 49. Asia-Pacific Burn and Scald Medicine Consumption Value Market Share by Region (2020-2031)
 Figure 50. China Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 51. Japan Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 52. South Korea Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 53. India Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 54. Southeast Asia Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 55. Australia Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 56. South America Burn and Scald Medicine Consumption Value Market Share by Type (2020-2031)
 Figure 57. South America Burn and Scald Medicine Consumption Value Market Share by Application (2020-2031)
 Figure 58. South America Burn and Scald Medicine Consumption Value Market Share by Country (2020-2031)
 Figure 59. Brazil Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 60. Argentina Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 61. Middle East & Africa Burn and Scald Medicine Consumption Value Market Share by Type (2020-2031)
 Figure 62. Middle East & Africa Burn and Scald Medicine Consumption Value Market Share by Application (2020-2031)
 Figure 63. Middle East & Africa Burn and Scald Medicine Consumption Value Market Share by Country (2020-2031)
 Figure 64. Turkey Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 65. Saudi Arabia Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 66. UAE Burn and Scald Medicine Consumption Value (2020-2031) & (USD Million)
 Figure 67. Burn and Scald Medicine Market Drivers
 Figure 68. Burn and Scald Medicine Market Restraints
 Figure 69. Burn and Scald Medicine Market Trends
 Figure 70. Porters Five Forces Analysis
 Figure 71. Burn and Scald Medicine Industrial Chain
 Figure 72. Methodology
 Figure 73. Research Process and Data Source

Companies Mentioned

Nipro
MediWound
STADA Arzneimittel
Elastoplast
Pfizer
Bharat Biotech
Paul Hartmann
Ono Pharmaceutical
Centaur Pharmaceuticals
Kedrion Biopharma
Smith & Nephew
ConvaTec
B. Braun Melsungen
Coloplast
Mölnlycke Health Care
Medline Industries
Hartmann
Ferndale Pharmaceuticals
Guizhou Jingcheng Medicine
Mebo Pharmaceutical Technology
Shanghai Tenry Pharm
Guilin Huanuo Gene Pharmaceutical
Shanghai Haohai Biotechnology
Beijing SL Pharmaceutical
Hubei Mayinglong Pharmaceutical
Jianmin Group
Tianjin Pharm Group
Cardinal Health
Integra LifeSciences
Deroyal
DermaRite Industries